華晨中國(01114.HK)附屬遭申索 已排期進行聆訊
華晨中國(01114.HK)公布,早前中國光大銀行針對附屬金杯汽控提起有關一項約18.18億元人民幣(下同)申索之法律程序,已排期於6月17日在瀋陽市中級人民法院進行聆訊。
金杯汽控近期接獲有關中國光大銀行針對金杯汽控及華晨汽車(鐵嶺)專用車有限公司提起有關一項約3,000萬元申索之法律程序之傳票及申訴狀,聆訊已排期於7月15日在瀋陽市中級人民法院進行。
金杯汽控現正尋求法律意見,並會採取適當行動對法律程序項下之申索提出積極抗辯。
公司股份自3月31日上午9時正起停牌,以待履行復牌指引,並將繼續暫停,直至另行通知為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.